Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer

Mitochondrial DNA

Volumn 23, Issue 4, 2012, Pages 251-254

  Ding, Cuimin ^a   Li, Ruijuan ^a   Wang, Ping ^a   Jin, Pule ^a   Li, Shengmian ^a   Guo, Zhanjun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

D Loop; Lung cancer; MtDNA; SNP

Indexed keywords

MITOCHONDRIAL DNA; NUCLEOTIDE;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HIGH RISK PATIENT; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOCHONDRIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMALL CELL LUNG CARCINOMA;

EID: 84863318622     PISSN: 19401736     EISSN: 19401744     Source Type: Journal    
DOI: 10.3109/19401736.2012.674120     Document Type: Article

References (35)

1. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. 2007. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687-4694. (Pubitemid 46910174)
2. Bandy B, Davision AJ. 1990. Mitochondrial mutations may increase oxidtaive stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:523-539. (Pubitemid 20204417)
3. Beal MF. 1996. Mitochondia, free radicals, and neurodegeneration. Curr Opin Neurobiol 6:661-666.
4. Cao C, Zhang YM, Wang R, Sun SF, Chen ZB, Ma HY, Yu YM, Ding QL, Shu LH, Deng ZC. 2011. Excision repair cross complementation group 1 polymorphisms and lung cancer risk: A meta-analysis. Chin Med J 124:2203-2208.
5. Dement GA, Maloney SC, Reeves R. 2007. Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp Cell Res 313: 77-87. (Pubitemid 44958455)
6. DiMauro S, Schon EA. 2001. Mitochondrial DNA mutations in human disease. Am J Med Genet 106:18-26. (Pubitemid 32601614)
7. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019. (Pubitemid 30158678)
8. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. 2008. Cigarette smoking and subsequent risk of lung cancer in men and women: Analysis of a prospective cohort study. Lancet Oncol 9:649-656.
9. Gille JJ, Joenje H. 1992. Cell culture models for oxidative stress: Superoxide and hydrogen peroxidative versus normobaric heperoxia. Mutat Res 275:405-414.
10. Jakupciak JP, Maragh S, Markowitz ME, Greenberg AK, Hoque MO, Maitra A, Barker PE, Wagner PD, Rom WN, Srivastava S, Sidransky D, O'Connell CD. 2008. Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer 8:285.
11. LawlessMW, O'Byme KJ, Gray SG. 2009. Oxidative stress induced lung cancer and COPD: Opportunities for epigenetic therapy. J Cell Mol Med 13:2800-2821.
12. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. 1997. Mammalian mitochondrial genetics: Heredity, heteroplasmy and disease. Trends Genet 13:450-455. (Pubitemid 27479904)
13. Lin G, Fang F, Yu XJ, Yu L. 2011. Meta-analysis of the relationship between p21 Ser31Arg polymorphism and lung cancer susceptibility. Genet Mol Res 13:2449-2456.
14. Loft S, Svoboda P, Kawai K, Kasai H, Sørensen M, Tjønneland A, Vogel U, Møller P, Overvad K, Raaschou-Nielsen O. 2012. Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med 52:167-172.
15. Mambo E, Gao X, Cohen Y, Guo Z, Talalay P, Sidransky D. 2003. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci USA 100:1838-1843. (Pubitemid 36254535)
16. Nashikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M. 2001. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61:1843-1845. (Pubitemid 32691996)
17. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, Pedrazzoli S, Plebani M. 2006. Mitochondrial DNAD-loop in pancreatic cancer: Somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol 126: 593-601. (Pubitemid 44498510)
18. Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. 2002. Mitochondrial D-loop mutation as clonal markers in multicentric hepatocellular carcimona and plasma. Clin Cancer Res 8:481-487. (Pubitemid 34193968)
19. Pandey M, Mathew A, Nair MK. 1999. Global perspective of tobacco habits and lung cancer: A lesson for third world countries. Eur J Cancer Prev 8:271-279. (Pubitemid 29418919)
20. Parkin DM, Bray FI, Devesa SS. 2001. Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4-S66.
21. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM, Sidransky D. 2001. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015-7019. (Pubitemid 32946487)
22. Schwarz KB. 1996. Oxidative stress during viral infection: A review. Free Radical Biol Med 21:641-649. (Pubitemid 26331094)
23. Spiro SG, Silvestri GA. 2005. One hundred years of lung cancer. Am J Respir Crit Care Med 172:523-529. (Pubitemid 41232963)
24. Stoneking M. 2000. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet 67: 1029-1032.
25. Taanman JW. 1999. The mitochondrial genome: Structure, transcription, translation and replication. Biochim Biophys Acta 1410:103-123.
26. Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S. 2011. Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg 59:527-537.
27. Wallace DC. 2001. Mouse models for mitochondrial disease. Am J Med Genet 106:71-93.
28. Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S, Guo Z. 2011. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun 406:493-496.
29. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. 2007. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16:1455-1459. (Pubitemid 47076878)
30. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, Schaid DJ, Thibodeau SN. 2008. Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17:3558-3566.
31. Xing D, Tan W, Wei Q, Lin D. 2002. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 38:123-129. (Pubitemid 35157754)
32. Yang L, Yang G, Zhou M, Smith M, Ge H, Boreham J, Hu Y, Peto R, Wang J, Chen Z. 2009. Body mass index and mortality from lung cancer in smokers and nonsmokers: A nationally representative prospective study of 220,000 men in China. Int J Cancer 125:2136-2143.
33. Yoneyama H, Hara T, Kato Y, Yamori T, Matsuura ET, Koike K. 2005. Nucleotide sequence variation is frequently in the mitochondrial DNA displacement loop region of individual human tumor cells. Mol Cancer Res 3:14-20. (Pubitemid 40189592)
34. Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, Wang C, Guo Z. 2010a. Single nucletide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 29:155.
35. Zhang R, Zhang F, Wang C, Wang S, Shiao YH, Guo Z. 2010b. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29:130.